Artigo Revisado por pares

Idiopathic thrombocytopenic purpura following measles–rubella‐conjugated vaccine

2007; Wiley; Volume: 49; Issue: 5 Linguagem: Inglês

10.1111/j.1442-200x.2007.02458.x

ISSN

1442-200X

Autores

Junichi Kitazawa, Katsuki Ohtani, Mutsuko Shiotani, Akira Satoh, Kazuhiko Sugimoto, Yumiko Nomura, RYUZO AOYAMA,

Tópico(s)

Immunodeficiency and Autoimmune Disorders

Resumo

Pediatrics InternationalVolume 49, Issue 5 p. 688-689 Idiopathic thrombocytopenic purpura following measles–rubella-conjugated vaccine JUNICHI KITAZAWA, Corresponding Author JUNICHI KITAZAWA 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanJunichi Kitazawa, MD PhD, Division of Transfusion Medicine and Department of Pediatrics, Kuroishi General Hospital, 1-70, Kitami-cho, Kuroishi-shi, Aomori 0360541, Japan. Email: [email protected]Search for more papers by this author 1,2 KATSUKI OHTANI, KATSUKI OHTANI 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 3 MUTSUKO SHIOTANI, MUTSUKO SHIOTANI 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 4 AKIRA SATOH, AKIRA SATOH 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 3 KAZUHIKO SUGIMOTO, KAZUHIKO SUGIMOTO 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 3 YUMIKO NOMURA, YUMIKO NOMURA 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 3 RYUZO AOYAMA, RYUZO AOYAMA 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 1 JUNICHI KITAZAWA, Corresponding Author JUNICHI KITAZAWA 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanJunichi Kitazawa, MD PhD, Division of Transfusion Medicine and Department of Pediatrics, Kuroishi General Hospital, 1-70, Kitami-cho, Kuroishi-shi, Aomori 0360541, Japan. Email: [email protected]Search for more papers by this author 1,2 KATSUKI OHTANI, KATSUKI OHTANI 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 3 MUTSUKO SHIOTANI, MUTSUKO SHIOTANI 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 4 AKIRA SATOH, AKIRA SATOH 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 3 KAZUHIKO SUGIMOTO, KAZUHIKO SUGIMOTO 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 3 YUMIKO NOMURA, YUMIKO NOMURA 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 3 RYUZO AOYAMA, RYUZO AOYAMA 1Department of Pediatrics and 2Division of Transfusion Medicine, Kuroishi General Hospital, Kuroishi, 3Department of Pediatrics, Hirosaki National Hospital, and 4Shiotani Internal Medicine and Pediatric Clinic, Hirosaki, JapanSearch for more papers by this author 1 First published: 14 September 2007 https://doi.org/10.1111/j.1442-200X.2007.02458.xCitations: 5Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Wilson DB. Acquired platelet defect. In: DG Nathan, SH Orkin, D Ginsburg, AT Look (eds). Hematology of Infancy and Childhood. Saunders, Philadelphia, 2003; 597–619. 2 Chen RT, Pless R, DeStefano F. Epidemiology of autoimmune reactions induced by vaccination. J. Autoimmun. 2001; 16: 309–18. 3 Shichino H, Japan Childhood ITP Study Group. Clinical analysis of childhood idiopathic thrombocytopenic purpura after vaccination. Jpn. J. Pediatr. Hematol. 2003; 17: 422–3. 4 Kitami N, Yamaguchi K. Diagnosis of drug allergy using peripheral blood lymphocytes. Clin. Immunol. 1983; 15: 727–36. 5 Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: What is the evidence? Lancet 2003; 362: 1659–66. 6 Jadavji T, Scheifele D, Halperin S, Canadian Paediatric Society/Health Canada Immunization Monitoring Program. Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatr. Infect. Dis. J. 2003; 22: 119–22. 7 Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br. J. Clin. Pharmacol. 2003; 55: 107–11. 8 Sanford R, Kimmel MD. Vaccine adverse events: myth separating from reality. Am. Fam. Physician 2002; 66: 2113–20. 9 Iyori H, Bessho F, Ookawa H et al. Intracranial hemorrhage in children with immune thrombocytopenic purpura. Japanese Study Group on childhood ITP. Ann. Hematol. 2000; 79: 691–5. 10 Shirahata S, Ishii E, Eguchi H et al. Consensus guideline for diagnosis and treatment of childhood idiopathic thrombocytopenic purpura. Int. J. Hematol. 2006; 83: 29–38. Citing Literature Volume49, Issue5October 2007Pages 688-689 ReferencesRelatedInformation

Referência(s)